Agios Pharmaceuticals (AGIO) Current Leases (2019 - 2025)
Historic Current Leases for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q3 2025 value amounting to $18.0 million.
- Agios Pharmaceuticals' Current Leases rose 1022.12% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 1022.12%. This contributed to the annual value of $16.8 million for FY2024, which is 1181.37% up from last year.
- As of Q3 2025, Agios Pharmaceuticals' Current Leases stood at $18.0 million, which was up 1022.12% from $17.6 million recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Current Leases registered a high of $18.0 million during Q3 2025, and its lowest value of $8.0 million during Q1 2021.
- In the last 5 years, Agios Pharmaceuticals' Current Leases had a median value of $14.3 million in 2023 and averaged $13.9 million.
- In the last 5 years, Agios Pharmaceuticals' Current Leases skyrocketed by 5265.75% in 2021 and then surged by 984.41% in 2023.
- Over the past 5 years, Agios Pharmaceuticals' Current Leases (Quarter) stood at $10.8 million in 2021, then grew by 26.18% to $13.7 million in 2022, then increased by 9.84% to $15.0 million in 2023, then increased by 11.81% to $16.8 million in 2024, then rose by 7.19% to $18.0 million in 2025.
- Its Current Leases stands at $18.0 million for Q3 2025, versus $17.6 million for Q2 2025 and $17.2 million for Q1 2025.